- Assistant Professor, CWRU School of Medicine
Naveen George, DO, MHSA, is a neurologist at the University Hospitals Neurological Institute specializing in headache medicine. Dr. George is also an assistant professor at Case Western Reserve University School of Medicine. He received his BA in Psychology and Philosophy at Brandeis University before attending medical school at Lake Erie College of Osteopathic Medicine. After earning his medical degree and master’s in health services administration, he completed his internship and neurology residency here at University Hospitals Cleveland Medical Center. Dr. George then completed a fellowship in headache medicine at Dartmouth-Hitchcock Medical Center before returning to University Hospitals to practice.
A member of both the American Headache Society and the International Headache Society, Dr. George specializes in the treatment of migraine, facial pain and other headache disorders. He is trained in Botox injections, occipital nerve blocks, trigger point injections and many other procedures used in the treatment of headache and facial pain. In addition to his outpatient headache practice, Dr. George is staff on the inpatient general neurology teaching service. In addition, Dr. George is actively involved in medical education at UH Cleveland Medical Center, including inpatient teaching rounds and formal instruction. Outside of his work at University Hospitals, he enjoys spending time with his two sons.
- Botox Injections for Migraine Headaches
- Facial Pain Syndromes
- Headache Management
- Migraine Headaches
- Occipital Nerve Blocks
- Sphenopalantine Ganglion Blocks
- Trigeminal Autonomic Cephalgias
- Neurology - American Board of Psychiatry and Neurology
Fellowship | Neurology-Headache
Neurology-Headache - Dartmouth-Hitchcock Medical Center (2020 - 2021)
Residency | Neurology
Neurology - UH Cleveland Medical Center (2016 - 2020)
Lake Erie College Of Osteopathic Medicine (2016)
Brandeis University (2010)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Naveen George did not disclose any Outside Relationships with Industry.